The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care

International Journal of Health Care Finance and Economics

Volumn 7, Issue 2-3, 2007, Pages 149-169

  Manns, Braden J ^a,b,c   Mendelssohn, David C ^d   Taub, Kenneth J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Dialysis; End stage renal disease; Health care financing; Medical costs; Reimbursement

Indexed keywords

ARTICLE; CANADA; CHRONIC KIDNEY FAILURE; DIALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PUBLIC HEALTH; REIMBURSEMENT; STATISTICAL MODEL; UTILIZATION REVIEW;

CANADA; DELIVERY OF HEALTH CARE; DIALYSIS; GUIDELINE ADHERENCE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, ECONOMETRIC; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; REIMBURSEMENT MECHANISMS;

EID: 34648832064     PISSN: 13896563     EISSN: 15736962     Source Type: Journal    
DOI: 10.1007/s10754-007-9022-y     Document Type: Article

References (59)

1. Alberta Blue Cross. (2005). Alberta health and wellness drug benefit list, 2005. Edmonton: Alberta Blue Cross. Retrieved September, 2005, at http://www.ab.bluecross.ca/dbl/publications.html.
2. Bargman J.M., Bick J., Cartier P., Dasgupta M.K., Fine A., Lavoie S.D., Spanner E., Taylor P.A. (1999) Guidelines for adequacy and nutrition in peritoneal dialysis. Journal of the American Society of Nephrology 10(Suppl 13): S311-S321
3. Casadevall N., Nataf J., Viron B., Kolta A., Kiladjian J.J., Martin-Dupont P., Michaud P., Papo T., Ugo V., Teyssandier I., Varet B., Mayeux P. (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine 346: 469-475
4. Churchill D.N., Blake P.G., Jindal K.K, Toffelmire E.B., Goldstein M.B. (1999) Clinical practice guidelines for initiation of dialysis. Journal of the American Society of Nephrology 10(Suppl 13): S289-S291
5. CIHI. (2002). From perceived surplus to perceived shortage: What happened to Canada's physician workforce in the 1990's? Ottawa: Canadian Institute for Health Information.
6. CIHI. (2003). Health care in Canada. Ottawa: Canadian Institute for Health Information.
7. CIHI. (2004). Average payment per physician report, Canada, 2002-2003. Ottawa: Canadian Institute for Health Information.
8. CIHI. (2005). Treatment of end-stage organ failure in Canada 2002 and 2003. Ottawa: Canadian Organ Replacement Register, Canadian Institute for Health Information.
9. Culleton, B. F., Gautam, M., Peterson, J., McVeigh, E., & Hons, R. (2003). Anemia management in hemodialysis patients is improved with a nurse-managed algorithm. Presented at the American Society of Nephrology Annual Meeting, San Diego.
10. Curtis B.M., Barrett B.J., Jindal K., Parfrey P. (2002) Canadian survey of clinical status at dialysis initiation 1998-1999: A multicenter prospective survey. Clinical Nephrology 58: 282-288
11. Curtis B.M., Ravani P., Malberti F., Kennett F., Taylor P.A., Djurdjev O., Levin A. (2005) The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrology Dialysis and Transplantation 20(1): 147-154
12. Dember L.M., Holmberg E.F., Kaufman J.S. (2004) Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney International 66: 390-398
13. Deziel C., Hirsch D.J., Hoult P., Levin A., Sohi P., Taub K.J., Watson D. (1999) Clinical practice guidelines for the delivery of hemodialysis. Journal of the American Society of Nephrology 10(Suppl 13): S306-S310
14. Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Care Finance and Economics. DOI: 10.1007/ s10754-007-9024-9
15. ERA-EDTA (2004). ERA-EDTA registry 2002 annual report. Amsterdam: Academic Medical Center.
16. Ethier J.H., Lindsay R.M., Barre P.E., Kappel J.E., Carlisle E.J., Common A. (1999) Clinical practice guidelines for vascular access. Journal of the American Society of Nephrology 10(Suppl 13): S297-S305
17. Fenton S.S., Schaubel D.E., Desmeules M., Morrison H.I., Mao Y., Copleston P., Jeffery J.R., Kjellstrand C.M. (1997) Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. American Journal of Kidney Diseases 30: 334-342
18. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., O'Dea R., Murray D.C., Barre P.E. (1998) Mode of dialysis therapy and mortality in end-stage renal disease. Journal of the American Society of Nephrology 9: 267-276
19. Goeree R., Manalich J., Grootendorst P., Beecroft M.L., Churchill D.N. (1995) Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clinical and Investigative Medicine 18: 455-464
20. Goldstein M., Yassa T., Dacouris N., McFarlane P. (2005) Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. American Journal of Kidney Diseases 44: 706-714
21. Hemmelgarn B.R., Zhang J., Manns B.J., Tonelli M., Larsen E., Ghali W.A., Southern D.A., McLaughlin K., Mortis G., Culleton B.F. (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney International 69(12): 2155-2161
22. Ifudu O., Dawood M., Homel P., Friedman E.A. (1998) Timing of initiation of uremia therapy and survival in patients with progressive renal disease. American Journal of Nephrology 18: 193-198
23. Jindal K.K., Chan C.T., Deziel C., Hirsch D., Soroko S.D., Tonelli M., Culleton B.F. (2006a) Chapter 1: Hemodialysis adequacy in adults. Journal of the American Society of Nephrology 17 (Suppl 1): S4-S7
24. Jindal K.K., Chan C.T., Deziel C., Hirsch D., Sorokoa S.D., Tonelli M., Cullenton B.F. (2006b) Chapter 2: Management of blood pressure in hemodialysis patients. Journal of the American Society of Nephrology 17(Suppl 1): S8-S10
25. Jindal K.K., Chan C.T., Deziel C., Hirsch D., Sorokoa S.D., Tonelli M., Cullenton B.F. (2006c) Chapter 3: Mineral metabolism. Journal of the American Society of Nephrology 17(Suppl 1): S11-S15
26. Jindal K.K., Chan C.T., Deziel C., Hirsch D., Soroko S.D., Tonelli M., Culleton B.F. (2006d) Chapter 4: Vascular access. Journal of the American Society of Nephrology 17(Suppl 1): S16-S23
27. Jindal K.K., Chan C.T., Deziel C., Hirsch D., Sorokoa S.D., Tonelli M., Cullenton B.F. (2006e) Chapter 5: Frequent and sustained hemodialysis. Journal of the American Society of Nephrology 17 (Suppl 1): S24-S27
28. Jindal K.K., Ethier J., Lindsay R.M., Barre P., Kappel J., Carlisle E., Common A. (1999) Clinical practice guidelines for vascular access. Journal of the American Society of Nephrology 10: S287-S321
29. Kjellstrand C.M., Moody H. (1994) Hemodilaysis in Canada: A first-class medical crisis. Canadian Medical Association Journal 150: 1067-1071
30. Laupacis A., Keown P., Pus N., Krueger H., Ferguson B., Wong C.M., Muirhead N. (1996) A study of the quality of life and cost-utility of renal transplantation. Kidney International 50: 235-242
31. Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnson D., Donaldson C. (2002) Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40: 611-622
32. Levin A., Lewis M., Mortiboy P., Faber S., Hare I., Porter E.C., Mendelssohn D.C. (1997) Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. American Journal of Kidney Diseases 29: 533-540
33. Manns B.J., Mortis G., Taub K., McLaughlin K., Donaldson C., Ghali W.A. (2001) The southern Alberta renal program database: A prototype for patient management and research initiatives. Clinical and Investigative Medicine 24(4): 164-170
34. Manns B., Taub K., Donaldson C. (2000) Economic evaluation and end-stage renal disease: Rrom basics to bedside. American Journal of Kidney Diseases 36: 12-28
35. Manns B.J., Taub K., Richardson R., Donaldson C. (2002) To reuse or not to reuse? An economic evaluation of hemodialyser reuse vs. conventional single use hemodialysis for chronic hemodialysis patients. International Journal of Technology Assessment in Health Care 18: 81-94
36. Manns B., Tonelli M., Yilmaz S., Lee H., Laupland K., Klarenbach S., Radkevich V., Murphy B. (2005) Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis. Journal of the American Society of Nephrology 16: 201-209
37. McKenzie J.K., Moss A.H., Feest T.G., Stocking C.B., Siegler M. (1998) Dialysis decision making in Canada, the United Kingdom, and the United States. American Journal of Kidney Diseases 31: 12-18
38. McMahon M., Morgan S., Mitton C. (2005) The common drug review: A NICE start for Canada? Health Policy 77(3): 339-351
39. Mendelssohn D.C., Barrett B.J., Brownscombe L.M., Ethier J., Greenberg D.E., Kanani S.D., Levin A., Toffelmire E.B. (1999) Elevated levels of serum creatinine: Recommendations for management and referral. Canadian Medical Association Journal 161: 413-417
40. Mendelssohn D.C., Chery A. (1994) Dialysis utilization in the Toronto region from 1981 to 1992: Toronto Region Dialysis Committee. Canadian Medical Association Journal 150: 1099-1105
41. Mendelssohn D.C., Ethier J., Elder S.J., Saran R., Port F.K., Pisoni R.L. (2006b) Hemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Neprhrology Dilaysis and Transplantation 21(3): 721-728
42. Mendelssohn D.C., Langlois N., Blake P.G. (2004) Peritoneal dialysis in Ontario: A natural experiment in physician reimbursement methodology. Peritoneal Dialysis International 24: 531-537
43. Mendelssohn D.C., Toffelmire E.B., Levin A. (2006c) Attitudes of Canadian nephrologists toward multidicisplinary team-based CKD clinic care. American Journal of Kidney Diseases 47: 277-284
44. Mendelssohn D.C., Yeates K., Ethier J., Trpeski L., Na Y., Bragg-Gresham J.L., Eichleay M.A., Pisoni R.L., Port F.K. (2007) DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Canada. Nephrology News and Issues 21(5): 69-85
45. Murphy S.W., Foley R.N., Barrett B.J., Kent G.M., Morgan J., Barre P., Campbell P., Fine A., Goldstein M.B., Handa S.P., Jindal K. K., Levin A., Mandin H., Muirhead N., Richardson R.M., Parfrey P.S. (2000) Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney International 57: 2557-2563
46. Nissenson A.R., Prichard S.S., Cheng I.K.P. (1993) Non-medical factors that impact on ESRD modality selection. Kidney International 43(Suppl 40): S120-S127
47. NKF. (1997). NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. American Journal of Kidney Diseases, 30, S192-S240.
48. NKF. (2001). NKF-DOQI clinical practice guidelines for vascular access: Update 2000. American Journal of Kidney Diseases, 37, S137-S181.
49. OECD. (2006). Purchasing power parities (PPPs) for OECD countries 1980-2005. Paris: Organization for Economic Cooperation and Development. Retreived April 28, 2006, at http://www.oecd.org/dataoecd/61/56/ 1876133.xls.
50. Pisoni R.L., Bragg-Gresham J.L., Young E.W., Akizawa T., Asano Y., Locatelli F., Bommer J., Cruz J.M., Kerr P.G., Mendelssohn D.C., Held P.J., Port F.K. (2004) Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 44(1): 94-111
51. Pisoni R.L., Gillespie B.W., Dickinson D.M., Chen K., Kutner M., Wolfe R.A. (2004) The dialysis outcomes and practice patterns study: Design, data elements, and methodology. American Journal of Kidney Diseases 44(Suppl 2): S7-S15
52. Ram S.J., Work J., Caldito G.C., Eason J.M., Pervez A., Paulson W.D. (2003) A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney International 64: 272-280
53. Scott's Medical Database (2001). Supply, distribution and migration of Canadian physicians, 2001. Ottawa: Canadian Institute for Health Information.
54. Sekkarie M., Cosma M., Mendelssohn D.C. (2001) Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States. American Journal of Kidney Diseases 38: 36-41
55. Tonelli M., Klarenbach S., Manns B., Culleton B., Hemmelgarn B., Bertazzon S., Wiebe N., Gill J. (2006) Alberta kidney disease network, residence location and likelihood of kidney transplantation. Canadian Medical Association Journal 175: 478-482
56. USRDS. (2003). United States renal data system 2003 annual data report: Atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
57. USRDS. (2004). United States renal data system 2004 annual data report: Atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
58. USRDS. (2005). United States renal data system 2005 annual data report: Atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
59. Walsh M., Culleton B., Tonelli M., Manns B. (2005) A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney International 67: 1500-1508